WASHINGTON, Jan 25 (Reuters) - U.S. biopharmaceutical company Phenomix Corp on Friday said it is planning an initial public offering of as much as $86.25 million in common stock.
WASHINGTON, Jan 25 (Reuters) - U.S. biopharmaceutical company Phenomix Corp on Friday said it is planning an initial public offering of as much as $86.25 million in common stock.